BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23548249)

  • 21. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
    de Martino M; Haitel A; Schatzl G; Klatte T
    J Urol; 2013 Oct; 190(4):1392-7. PubMed ID: 23517743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.
    Tiseo M; Giovannetti E; Tibaldi C; Camerini A; Di Costanzo F; Barbieri F; Burgers JA; Vincent A; Peters GJ; Smit EF; Ardizzoni A
    Lung Cancer; 2012 Oct; 78(1):92-9. PubMed ID: 22889494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
    Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
    Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
    Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
    Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
    Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
    J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
    Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
    Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancer.
    Reinmuth N; Kloos S; Warth A; Risch A; Muley T; Hoffmann H; Thomas M; Meister M
    Hum Pathol; 2014 Jun; 45(6):1162-8. PubMed ID: 24745618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.
    Lurje G; Husain H; Power DG; Yang D; Groshen S; Pohl A; Zhang W; Ning Y; Manegold PC; El-Khoueiry A; Iqbal S; Tang LH; Shah MA; Lenz HJ
    Ann Oncol; 2010 Jan; 21(1):78-86. PubMed ID: 19622587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pri-let-7a-2 rs1143770C>T is associated with prognosis of surgically resected non-small cell lung cancer.
    Shin KM; Jung DK; Hong MJ; Kang HJ; Lee WK; Yoo SS; Lee SY; Cha SI; Lee J; Kim CH; Seok Y; Cho S; Son JW; Lee EB; Jheon S; Kim YT; Park JY
    Gene; 2016 Feb; 577(2):148-52. PubMed ID: 26625972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
    Jin G; Miao R; Hu Z; Xu L; Huang X; Chen Y; Tian T; Wei Q; Boffetta P; Shen H
    Int J Cancer; 2009 May; 124(9):2172-8. PubMed ID: 19132754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection.
    Lee SY; Choi JE; Jeon HS; Choi YY; Lee WK; Lee EB; Lee HC; Kang HG; Yoo SS; Lee J; Cha SI; Kim CH; Lee MH; Kim YT; Jheon S; Park JY
    PLoS One; 2015; 10(10):e0140216. PubMed ID: 26462029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer.
    Gao L; Zhang H; Zhang B; Zhu J; Chen C; Liu W
    J Clin Pathol; 2018 Jul; 71(7):642-647. PubMed ID: 29483137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.